Week of wild­fires now dead­li­est in Calif. his­tory

The Detroit News - - Front Page -

Sonoma, Calif. — Teams with ca­daver dogs be­gan a grim search Thurs­day for more dead in parts of Cal­i­for­nia wine coun­try dev­as­tated by wild­fires, re­sort­ing in some cases to se­rial num­bers stamped on med­i­cal im­plants to iden­tify re­mains that turned up in the charred ru­ins.

New deaths con­firmed Thurs­day took the toll to 31, mak­ing this the dead­li­est week of wild­fires in Cal­i­for­nia his­tory.

Many of the flames still burned out of con­trol, and the fires grew to more than 777 square kilo­me­ters, an area as large as New York City.

Sonoma and Napa coun­ties en­dured a fourth day of chok­ing smoke while many res­i­dents fled to shel­ters or camped out on beaches to await word on their homes and loved ones. At least 3,500 homes and busi­nesses have been de­stroyed and an es­ti­mated 25,000 peo­ple forced to flee.

A fore­cast for gusty winds and dry air threat­ened to fan the fires fur­ther.

FBI: Mo­tive in Ve­gas shoot­ing un­clear

At­lanta — The FBI di­rec­tor said Thurs­day that in­ves­ti­ga­tors haven’t yet de­ter­mined a mo­tive be­hind the mass shoot­ing at a Las Ve­gas coun­try mu­sic fes­ti­val, but they’re still dig­ging.

“There’s a lot of ef­fort be­ing put into un­rav­el­ing this hor­rific act,” Di­rec­tor Christo­pher Wray told re­porters fol­low­ing a rib­bon-cut­ting for the FBI’s new At­lanta build­ing. “We don’t know yet what the mo­tive is, but that’s not for lack of try­ing, and if you know any­thing about the bu­reau we don’t give up easy.”

Au­thor­i­ties have said Stephen Pad­dock tar­geted the coun­try mu­sic fes­ti­val the night of Oct. 1, open­ing fire from the 32nd floor of the Man­dalay Bay ho­tel and killing 58 peo­ple.

In other head­lines

FDA ad­vis­ers en­dorse gene ther­apy to treat form of blind­ness: A po­ten­tially ground­break­ing treat­ment for a rare form of blind­ness moved one step closer to U.S. ap­proval Thurs­day, as fed­eral health ad­vis­ers en­dorsed the ex­per­i­men­tal gene ther­apy for pa­tients with an in­her­ited con­di­tion that grad­u­ally de­stroys eye­sight.

The panel ex­perts to the Food and Drug Ad­min­is­tra­tion voted unan­i­mously in fa­vor of Spark Ther­a­peu­tics’ in­jectable ther­apy, which aims to im­prove vi­sion by re­plac­ing a de­fec­tive gene needed to process light. The FDA has un­til mid-Jan­uary to make its de­ci­sion.


Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.